Bortezomib (10nM) treatment of myeloma cells led to a dramatic induction of GRP78 that accumulated near the cell membrane as shown by immunohistochemistry (IHC) and confocal microscopy (Figure 1C, D). The gene discussed is HSPA5; the disease is plasma cell myeloma.